User profiles for "author:M Tabone"

Michaelangelo Tabone

Software Engineer, Google Nest
Verified email at berkeley.edu
Cited by 1048

Risk–benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling

P Reichardt, MD Tabone, J Mora, B Morland… - Future …, 2018 - Future Medicine
Dexrazoxane can prevent anthracycline-associated cardiotoxicity. However, in 2011, its use
in children was contraindicated by the EMA over concerns of increased risk of infection …

Clinical spectrum of X-linked hyper-IgM syndrome

J Levy, T Espanol-Boren, C Thomas, A Fischer… - The Journal of …, 1997 - Elsevier
We report the clinical and immunologic features and outcome in 56 patients with X-linked
hyper-IgM syndrome, a disorder caused by mutations in the CD40 ligand gene. Upper and …

Sustainability metrics: life cycle assessment and green design in polymers

MD Tabone, JJ Cregg, EJ Beckman… - … science & technology, 2010 - ACS Publications
This study evaluates the efficacy of green design principles such as the “12 Principles of
Green Chemistry,” and the “12 Principles of Green Engineering” with respect to …

Prognostic factors and outcomes for osteosarcoma: an international collaboration

EE Pakos, AD Nearchou, RJ Grimer… - European journal of …, 2009 - Elsevier
We aimed to evaluate the prognostic significance of traditional clinical predictors in
osteosarcoma through an international collaboration of 10 teams of investigators (2680 …

Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis

F Lanternier, S Poiree, C Elie… - Journal of …, 2015 - academic.oup.com
Background Mucormycosis incidence is increasing and is associated with a high rate of
mortality. Although lipid-based formulations of amphotericin B are the recommended first …

Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial

S Piperno-Neumann, MC Le Deley, F Rédini… - The Lancet …, 2016 - thelancet.com
Background Based on preclinical data for the antitumour effect of zoledronate in
osteosarcoma, we assessed whether zoledronate combined with chemotherapy and surgery …

SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in …

MC Le Deley, JM Guinebretière, JC Gentet… - European journal of …, 2007 - Elsevier
The SFOP-OS94 randomised multi-centre trial was designed to determine whether
preoperative chemotherapy regimen combining high-dose methotrexate courses and …

Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.

MD Tabone, C Kalifa, C Rodary, M Raquin… - Journal of Clinical …, 1994 - ascopubs.org
PURPOSE AND METHODS Between January 1981 and June 1993, 137 children and
adolescents were each treated at the Institut Gustave Roussy for an initially nonmetastatic …

Using smart meter data to estimate demand response potential, with application to solar energy integration

MEH Dyson, SD Borgeson, MD Tabone, DS Callaway - Energy Policy, 2014 - Elsevier
This paper presents a new method for estimating the demand response potential of
residential air conditioning (A/C), using hourly electricity consumption data (“smart meter” …

High serum leptin concentrations during catch-up growth of children born with intrauterine growth retardation

D Jaquet, J Leger, MD Tabone… - The Journal of …, 1999 - academic.oup.com
The aim of the study was to investigate how leptin could be involved in catch-up growth of
children born with intrauterine growth retardation (IUGR). The study population was made …